Stocks / Stock overview
Hims & Hers Health, Inc. (HIMS)
$33.78+6.03%Aft $33.80 (+0.06%)Market cap $7.88B
NYSE · Price as of · Nasdaq Real Time Price
Stock Scorer
Scoring…
Analyst consensus
$30.85
- Analysts13
- Implied upside-8.7%
- Target range$23.00 to $42.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
in 78 days
- EPS expected-$0.05 -129%
- A year ago$0.17
- Revenue expected$730.1M +34%
- Estimate range-$0.06 to -$0.04
Consensus of 2 analysts for the quarter ended June 30, 2026. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | August 20, 2026 | FORM 4 |
| 4 | August 20, 2026 | FORM 4 |
| 4 | August 20, 2026 | FORM 4 |
| 144 | August 19, 2026 | View on EDGAR |
| 4 | August 18, 2026 | FORM 4 |
| 4 | August 18, 2026 | FORM 4 |
| 4 | August 18, 2026 | FORM 4 |
| 4 | August 18, 2026 | FORM 4 |
Frequently asked questions
When does HIMS report earnings?
Hims & Hers Health, Inc. (HIMS) is scheduled to report quarterly results on November 9, 2026. The 2-analyst consensus is -$0.05 per share on revenue of $730.1M for the quarter ended June 30, 2026, against $0.17 and $544.8M a year earlier.
What do analysts expect for HIMS?
13 analysts cover Hims & Hers Health, Inc. (HIMS). The consensus rating is Hold. The average price target is $30.85, in a range of $23.00 to $42.00.
Are insiders buying or selling HIMS?
We have no qualifying Form 4 insider purchases or sales on record for Hims & Hers Health, Inc. (HIMS). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see HIMS SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed August 20, 2026.
Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.